Literature DB >> 26242770

Inactivating effects of the lactoperoxidase system on bacterial lyases involved in oral malodour production.

Manabu Nakano1, Kouichirou Shin1, Hiroyuki Wakabayashi1, Koji Yamauchi1, Fumiaki Abe1, Shouji Hironaka2.   

Abstract

The main components of oral malodour have been identified as volatile sulfur compounds (VSCs), including hydrogen sulfide (H(2)S) and methyl mercaptan (CH(3)SH). The lactoperoxidase (LPO) system (consisting of LPO, glucose oxidase, glucose and thiocyanate) was previously shown to exhibit antimicrobial activities against some oral bacteria in vitro and suppressive effects on VSCs in mouth air in a clinical trial. Here, we examined the in vitro effects of the LPO system on the activities of the bacterial lyases involved in the production of VSCs by oral anaerobes. The exposure of crude bacterial extracts of Fusobacterium nucleatum and Porphyromonas gingivalis or purified methionine γ-lyase to the LPO system resulted in the inactivation of their lyase activities through l-cysteine and l-methionine, which was linked to the production of H(2)S and CH(3)SH, respectively. The exposure of living F. nucleatum and P. gingivalis cells to the LPO system resulted in the suppression of cell numbers and lyase activities. The inactivation of the crude bacterial extracts of F. nucleatum and purified methionine γ-lyase by the LPO system was partly recovered by the addition of DTT. Therefore, the LPO system may inactivate bacterial lyases including methionine γ-lyase by reacting with the free cysteine residues of lyases. These results suggested that the LPO system suppresses the production of VSCs not only through its antimicrobial effects, but also by its inactivating effects on the bacterial lyases of F. nucleatum and P. gingivalis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26242770     DOI: 10.1099/jmm.0.000150

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  2 in total

1.  Effect of thymoquinone on Fusobacterium nucleatum‑associated biofilm and inflammation.

Authors:  Ayano Tada; Haruyuki Nakayama-Imaohji; Hisashi Yamasaki; Miad Elahi; Tamiko Nagao; Hirofumi Yagi; Masao Ishikawa; Koji Shibuya; Tomomi Kuwahara
Journal:  Mol Med Rep       Date:  2020-05-07       Impact factor: 2.952

2.  A randomized, double-blind, crossover, placebo-controlled clinical trial to assess effects of the single ingestion of a tablet containing lactoferrin, lactoperoxidase, and glucose oxidase on oral malodor.

Authors:  Manabu Nakano; Eiju Shimizu; Hiroyuki Wakabayashi; Koji Yamauchi; Fumiaki Abe
Journal:  BMC Oral Health       Date:  2016-03-22       Impact factor: 2.757

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.